{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:57:28Z","timestamp":1774083448991,"version":"3.50.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503401"],"award-info":[{"award-number":["82503401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572542"],"award-info":[{"award-number":["81572542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Engineering Team, Discipline Cultivation Projects, Guangdong Pharmaceutical University","award":["2024ZZ10"],"award-info":[{"award-number":["2024ZZ10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10495-026-02280-8","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:52:54Z","timestamp":1770666774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell adhesion molecules as emerging regulators of ferroptosis: mechanisms and therapeutic opportunities in cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Shiwen","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Suo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linglong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"1","key":"2280_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"issue":"22","key":"2280_CR2","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.3390\/ijms20225579","volume":"20","author":"J Zaheer","year":"2019","unstructured":"Zaheer J, Kim H, Lee YJ, Kim JS, Lim SM (2019) Combination radioimmunotherapy strategies for solid tumors. Int J Mol Sci 20(22):5579","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2280_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1570163812666150602144310","volume":"12","author":"TA Baudino","year":"2015","unstructured":"Baudino TA (2015) Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol 12(1):3\u201320","journal-title":"Curr Drug Discov Technol"},{"issue":"3","key":"2280_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/jso.26416","volume":"123","author":"JM Keilson","year":"2021","unstructured":"Keilson JM, Knochelmann HM, Paulos CM, Kudchadkar RR, Lowe MC (2021) The evolving landscape of immunotherapy in solid tumors. J Surg Oncol 123(3):798\u2013806","journal-title":"J Surg Oncol"},{"issue":"7","key":"2280_CR5","first-page":"1408","volume":"58","author":"JM Brown","year":"1998","unstructured":"Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58(7):1408\u20131416","journal-title":"Cancer Res"},{"key":"2280_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fcell.2020.00672","volume":"8","author":"Q Lei","year":"2020","unstructured":"Lei Q, Wang D, Sun K, Wang L, Zhang Y (2020) Resistance mechanisms of anti-PD1\/PDL1 therapy in solid tumors. Front Cell Dev Biol 8:672","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2280_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13287-020-02128-1","volume":"12","author":"F Marofi","year":"2021","unstructured":"Marofi F, Motavalli R, Safonov VA, Thangavelu L, Yumashev AV, Alexander M, Shomali N, Chartrand MS, Pathak Y, Jarahian M et al (2021) CAR T cells in solid tumors: challenges and opportunities. Stem Cell Res Ther 12(1):81","journal-title":"Stem Cell Res Ther"},{"key":"2280_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.semcancer.2023.11.006","volume":"98","author":"C Beckers","year":"2024","unstructured":"Beckers C, Pruschy M, Vetrugno I (2024) Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities. Semin Cancer Biol 98:19\u201330","journal-title":"Semin Cancer Biol"},{"issue":"19","key":"2280_CR9","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jnci\/djm135","volume":"99","author":"O Tr\u00e9dan","year":"2007","unstructured":"Tr\u00e9dan O, Galmarini CM, Patel K, Tannock IF (2007) Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99(19):1441\u20131454","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2280_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/biom10050666","volume":"10","author":"E Koustas","year":"2020","unstructured":"Koustas E, Sarantis P, Papavassiliou AG, Karamouzis MV (2020) The resistance mechanisms of checkpoint inhibitors in solid tumors. Biomolecules 10(5):666","journal-title":"Biomolecules"},{"issue":"2","key":"2280_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00428-017-2101-7","volume":"471","author":"LJ Tafe","year":"2017","unstructured":"Tafe LJ (2017) Molecular mechanisms of therapy resistance in solid tumors: chasing moving targets. Virchows Arch 471(2):155\u2013164","journal-title":"Virchows Arch"},{"issue":"7679","key":"2280_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL et al (2017) Drug-tolerant persister cancer cells are vulnerable to GPX4 Inhibition. Nature 551(7679):247\u2013250","journal-title":"Nature"},{"issue":"7664","key":"2280_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ et al (2017) Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547(7664):453\u2013457","journal-title":"Nature"},{"issue":"5","key":"2280_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, Wong DJL, Atefi M, Shirazi R, Wang X et al (2018) Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell 33(5):890\u2013904e895","journal-title":"Cancer Cell"},{"issue":"2","key":"2280_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, Zhang C, Zhou F, Chen J, Zhang L (2022) Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond) 42(2):88\u201311616","journal-title":"Cancer Commun (Lond)"},{"issue":"4","key":"2280_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"22","key":"2280_CR17","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang D (2022) Signaling pathways and defense mechanisms of ferroptosis. Febs J 289(22):7038\u20137050","journal-title":"Febs J"},{"issue":"11","key":"2280_CR18","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/sj.onc.1210796","volume":"27","author":"A Banjac","year":"2008","unstructured":"Banjac A, Perisic T, Sato H, Seiler A, Bannai S, Weiss N, K\u00f6lle P, Tschoep K, Issels RD, Daniel PT et al (2008) The cystine\/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death. Oncogene 27(11):1618\u20131628","journal-title":"Oncogene"},{"issue":"4","key":"2280_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jcmm.13008","volume":"21","author":"H Yu","year":"2017","unstructured":"Yu H, Guo P, Xie X, Wang Y, Chen G (2017) Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med 21(4):648\u2013657","journal-title":"J Cell Mol Med"},{"issue":"5","key":"2280_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072","journal-title":"Cell"},{"issue":"6","key":"2280_CR21","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1158\/1541-7786.MCR-18-0910","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Zhou Z, Yang H, Jiao F, Li N, Gao Y, Wang L, Chen J, Quan M (2019) MST1 suppresses pancreatic cancer progression via ROS-induced pyroptosis. Mol Cancer Res 17(6):1316\u20131325","journal-title":"Mol Cancer Res"},{"issue":"2","key":"2280_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM (2024) Cell death. Cell 187(2):235\u2013256","journal-title":"Cell"},{"issue":"2","key":"2280_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ymeth.2013.06.001","volume":"61","author":"SJ Martin","year":"2013","unstructured":"Martin SJ, Henry CM (2013) Distinguishing between apoptosis, necrosis, necroptosis and other cell death modalities. Methods 61(2):87\u201389","journal-title":"Methods"},{"issue":"3","key":"2280_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrm3068","volume":"12","author":"U Cavallaro","year":"2011","unstructured":"Cavallaro U, Dejana E (2011) Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol 12(3):189\u2013197","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2280_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrm3769","volume":"15","author":"SE Winograd-Katz","year":"2014","unstructured":"Winograd-Katz SE, F\u00e4ssler R, Geiger B, Legate KR (2014) The integrin adhesome: from genes and proteins to human disease. Nat Rev Mol Cell Biol 15(4):273\u2013288","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2280_CR26","doi-asserted-by":"crossref","unstructured":"Al-Hadi M, Nikonenko AG, Sytnyk V (2025) The reciprocal relationship between cell adhesion molecules and reactive oxygen species. Cells 14 (14)","DOI":"10.3390\/cells14141098"},{"key":"2280_CR27","doi-asserted-by":"publisher","first-page":"106363","DOI":"10.1016\/j.biocel.2023.106363","volume":"156","author":"L Jun","year":"2023","unstructured":"Jun L, Chen W, Han L, Yanmin L, Qinglei Z, Pengfei Z (2023) Protocadherin 20 promotes ferroptosis by suppressing the expression of Sirtuin 1 and promoting the acetylation of nuclear factor erythroid 2-related factor 2 in hepatocellular carcinoma. Int J Biochem Cell Biol 156:106363","journal-title":"Int J Biochem Cell Biol"},{"issue":"44","key":"2280_CR28","doi-asserted-by":"publisher","first-page":"52374","DOI":"10.1021\/acsami.1c14944","volume":"13","author":"A Qi","year":"2021","unstructured":"Qi A, Wang C, Ni S, Meng Y, Wang T, Yue Z, Yang K, Li Y, Cheng Z, Guo P et al (2021) Intravesical mucoadhesive hydrogel induces chemoresistant bladder cancer ferroptosis through delivering iron oxide nanoparticles in a three-tier strategy. ACS Appl Mater Interfaces 13(44):52374\u201352384","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"2280_CR29","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/cells11101685","volume":"11","author":"CG Gahmberg","year":"2022","unstructured":"Gahmberg CG, Gr\u00f6nholm M, Madhavan S (2022) Regulation of dynamic cell adhesion by integrin-integrin crosstalk. Cells 11(10):1685","journal-title":"Cells"},{"issue":"3","key":"2280_CR30","doi-asserted-by":"publisher","first-page":"e1356900","DOI":"10.1080\/21688370.2017.1356900","volume":"5","author":"NA Gloushankova","year":"2017","unstructured":"Gloushankova NA, Rubtsova SN, Zhitnyak IY (2017) Cadherin-mediated cell-cell interactions in normal and cancer cells. Tissue Barriers 5(3):e1356900","journal-title":"Tissue Barriers"},{"key":"2280_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-94-007-4186-7_7","volume":"60","author":"Y Shimono","year":"2012","unstructured":"Shimono Y, Rikitake Y, Mandai K, Mori M, Takai Y (2012) Immunoglobulin superfamily receptors and adherens junctions. Subcell Biochem 60:137\u2013170","journal-title":"Subcell Biochem"},{"issue":"12","key":"2280_CR32","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/biom11121850","volume":"11","author":"M Hassn Mesrati","year":"2021","unstructured":"Hassn Mesrati M, Syafruddin SE, Mohtar MA, Syahir A (2021) CD44: A multifunctional mediator of cancer progression. Biomolecules 11(12):1850","journal-title":"Biomolecules"},{"issue":"9","key":"2280_CR33","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/glycob\/cwx105","volume":"28","author":"L Borsig","year":"2018","unstructured":"Borsig L (2018) Selectins in cancer immunity. Glycobiology 28(9):648\u2013655","journal-title":"Glycobiology"},{"issue":"20","key":"2280_CR34","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.3390\/ijms21207624","volume":"21","author":"I Kaszak","year":"2020","unstructured":"Kaszak I, Witkowska-Pi\u0142aszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P (2020) Role of cadherins in cancer-a review. Int J Mol Sci 21(20):7624","journal-title":"Int J Mol Sci"},{"issue":"7769","key":"2280_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, Chen ZN, Jiang X (2019) Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature 572(7769):402\u2013406","journal-title":"Nature"},{"key":"2280_CR36","doi-asserted-by":"publisher","first-page":"101697","DOI":"10.1016\/j.redox.2020.101697","volume":"37","author":"J Lee","year":"2020","unstructured":"Lee J, You JH, Kim MS, Roh JL (2020) Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Redox Biol 37:101697","journal-title":"Redox Biol"},{"issue":"12","key":"2280_CR37","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1083\/jcb.201701136","volume":"216","author":"CW Brown","year":"2017","unstructured":"Brown CW, Amante JJ, Goel HL, Mercurio AM (2017) The \u03b16\u03b24 integrin promotes resistance to ferroptosis. J Cell Biol 216(12):4287\u20134297","journal-title":"J Cell Biol"},{"issue":"5","key":"2280_CR38","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00204-019-02413-w","volume":"93","author":"C Wenz","year":"2019","unstructured":"Wenz C, Faust D, Linz B, Turmann C, Nikolova T, Dietrich C (2019) Cell-cell contacts protect against t-BuOOH-induced cellular damage and ferroptosis in vitro. Arch Toxicol 93(5):1265\u20131279","journal-title":"Arch Toxicol"},{"issue":"1","key":"2280_CR39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00726-011-0867-5","volume":"42","author":"M Conrad","year":"2012","unstructured":"Conrad M, Sato H (2012) The oxidative stress-inducible cystine\/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids 42(1):231\u2013246","journal-title":"Amino Acids"},{"issue":"1\u20132","key":"2280_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1\u20132):317\u2013331","journal-title":"Cell"},{"issue":"1","key":"2280_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2017.7115","volume":"29","author":"M Maiorino","year":"2018","unstructured":"Maiorino M, Conrad M, Ursini F (2018) GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid Redox Signal 29(1):61\u201374","journal-title":"Antioxid Redox Signal"},{"issue":"7784","key":"2280_CR42","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575(7784):688\u2013692","journal-title":"Nature"},{"key":"2280_CR43","doi-asserted-by":"crossref","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva T N, Panzilius E, Scheel CH et al (2019) FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575 (7784): 693\u2013698","DOI":"10.1038\/s41586-019-1707-0"},{"issue":"1","key":"2280_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, M\u00fcller C, Zandkarimi F, Merl-Pham J, Bao X, Anastasov N, K\u00f6ssl J et al (2020) GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci 6(1):41\u201353","journal-title":"ACS Cent Sci"},{"issue":"7873","key":"2280_CR45","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1038\/s41586-021-03820-9","volume":"596","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B et al (2021) Author correction: DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 596(7873):E13","journal-title":"Nature"},{"issue":"2","key":"2280_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X (2015) Glutaminolysis and transferrin regulate ferroptosis. Mol Cell 59(2):298\u2013308","journal-title":"Mol Cell"},{"issue":"12","key":"2280_CR47","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2012.063974","volume":"97","author":"F Zhang","year":"2012","unstructured":"Zhang F, Tao Y, Zhang Z, Guo X, An P, Shen Y, Wu Q, Yu Y, Wang F (2012) Metalloreductase Steap3 coordinates the regulation of iron homeostasis and inflammatory responses. Haematologica 97(12):1826\u20131835","journal-title":"Haematologica"},{"issue":"6641","key":"2280_CR48","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/41343","volume":"388","author":"H Gunshin","year":"1997","unstructured":"Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388(6641):482\u2013488","journal-title":"Nature"},{"issue":"7498","key":"2280_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509(7498):105\u2013109","journal-title":"Nature"},{"issue":"5704","key":"2280_CR50","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to Ferroportin and inducing its internalization. Science 306(5704):2090\u20132093","journal-title":"Science"},{"issue":"2","key":"2280_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0891-5849(02)00855-9","volume":"33","author":"H K\u00fchn","year":"2002","unstructured":"K\u00fchn H, Borchert A (2002) Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes. Free Radic Biol Med 33(2):154\u2013172","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"2280_CR52","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon SJ, Winter GE, Musavi LS, Lee ED, Snijder B, Rebsamen M, Superti-Furga G, Stockwell BR (2015) Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol 10(7):1604\u20131609","journal-title":"ACS Chem Biol"},{"issue":"13","key":"2280_CR53","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR, Jiang X (2023) Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 186(13):2748\u20132764e2722","journal-title":"Cell"},{"key":"2280_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.vh.2022.09.002","volume":"121","author":"DA Averill-Bates","year":"2023","unstructured":"Averill-Bates DA (2023) The antioxidant glutathione. Vitam Horm 121:109\u2013141","journal-title":"Vitam Horm"},{"issue":"6","key":"2280_CR55","doi-asserted-by":"publisher","first-page":"e2204006","DOI":"10.1002\/advs.202204006","volume":"10","author":"D Liu","year":"2023","unstructured":"Liu D, Liang CH, Huang B, Zhuang X, Cui W, Yang L, Yang Y, Zhang Y, Fu X, Zhang X et al (2023) Tryptophan metabolism acts as a new anti-ferroptotic pathway to mediate tumor growth. Adv Sci (Weinh) 10(6):e2204006","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2280_CR56","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41467-024-46776-w","volume":"15","author":"G Bi","year":"2024","unstructured":"Bi G, Liang J, Bian Y, Shan G, Huang Y, Lu T, Zhang H, Jin X, Chen Z, Zhao M et al (2024) Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer. Nat Commun 15(1):2461","journal-title":"Nat Commun"},{"key":"2280_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.freeradbiomed.2024.08.001","volume":"223","author":"W Jiang","year":"2024","unstructured":"Jiang W, Yu L, Mu N, Zhang Z, Ma H (2024) MG53 inhibits ferroptosis by targeting the p53\/SLC7A11\/GPX4 pathway to alleviate doxorubicin-induced cardiotoxicity. Free Radic Biol Med 223:224\u2013236","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"2280_CR58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","volume":"21","author":"B Chu","year":"2019","unstructured":"Chu B, Kon N, Chen D, Li T, Liu T, Jiang L, Song S, Tavana O, Gu W (2019) ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol 21(5):579\u2013591","journal-title":"Nat Cell Biol"},{"issue":"44","key":"2280_CR59","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang SJ, Li D, Chu B, Gu W (2016) Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A 113(44):E6806\u2013e6812","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"2280_CR60","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","volume":"28","author":"X Song","year":"2018","unstructured":"Song X, Zhu S, Chen P, Hou W, Wen Q, Liu J, Xie Y, Liu J, Klionsky DJ, Kroemer G et al (2018) AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system X(c)(-) activity. Curr Biol 28(15):2388\u20132399e2385","journal-title":"Curr Biol"},{"issue":"2","key":"2280_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cell.2020.06.007","volume":"182","author":"E Verschueren","year":"2020","unstructured":"Verschueren E, Husain B, Yuen K, Sun Y, Paduchuri S, Senbabaoglu Y, Lehoux I, Arena TA, Wilson B, Lianoglou S et al (2020) The Immunoglobulin superfamily receptome defines cancer-relevant networks associated with clinical outcome. Cell 182(2):329\u2013344e319","journal-title":"Cell"},{"issue":"D1","key":"2280_CR62","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, Wu J, Tang H, Zheng S, Liu Y et al (2025) Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucl Acids Res 53(D1):D1670\u2013d1676","journal-title":"Nucl Acids Res"},{"key":"2280_CR63","doi-asserted-by":"publisher","first-page":"964442","DOI":"10.3389\/fimmu.2022.964442","volume":"13","author":"Q Tang","year":"2022","unstructured":"Tang Q, Chen Y, Li X, Long S, Shi Y, Yu Y, Wu W, Han L, Wang S (2022) The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Immunol 13:964442","journal-title":"Front Immunol"},{"issue":"6","key":"2280_CR64","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","volume":"209","author":"T Yokosuka","year":"2012","unstructured":"Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, Hashimoto-Tane A, Azuma M, Saito T (2012) Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med 209(6):1201\u20131217","journal-title":"J Exp Med"},{"issue":"11","key":"2280_CR65","doi-asserted-by":"publisher","first-page":"114868","DOI":"10.1016\/j.celrep.2024.114868","volume":"43","author":"K Xiao","year":"2024","unstructured":"Xiao K, Zhang S, Peng Q, Du Y, Yao X, Ng II, Tang H (2024) PD-L1 protects tumor-associated dendritic cells from ferroptosis during Immunogenic chemotherapy. Cell Rep 43(11):114868","journal-title":"Cell Rep"},{"key":"2280_CR66","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.freeradbiomed.2023.12.034","volume":"212","author":"T Li","year":"2024","unstructured":"Li T, Huang HY, Qian B, Wang WH, Yuan Q, Zhang HY, He J, Ni KJ, Wang P, Zhao ZY et al (2024) Interventing mitochondrial PD-L1 suppressed IFN-\u03b3-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis. Free Radic Biol Med 212:360\u2013374","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"2280_CR67","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.chembiol.2024.10.014","volume":"31","author":"M Wang","year":"2024","unstructured":"Wang M, Prachyathipsakul T, Silva CA, Xiong C, Goel S, Goel HL, Karner ER, Mukhopadhyay D, Gupta P, Majee A et al (2024) Therapeutic induction of ferroptosis in tumors using PD-L1 targeting antibody nanogel conjugates. Cell Chem Biol 31(12):2039\u20132051 e2036","journal-title":"Cell Chem Biol"},{"issue":"5","key":"2280_CR68","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.7150\/thno.109534","volume":"15","author":"HQ Ju","year":"2025","unstructured":"Ju HQ, Lu YX, Chen DL, Tian T, Mo HY, Wei XL, Liao JW, Wang F, Zeng ZL, Pelicano H et al (2025) Erratum: Redox regulation of stem-like cells though the CD44v-xCT axis in colorectal cancer: mechanisms and therapeutic implications: erratum. Theranostics 15(5):2090\u20132091","journal-title":"Theranostics"},{"issue":"3","key":"2280_CR69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","volume":"19","author":"T Ishimoto","year":"2011","unstructured":"Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H et al (2011) CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19(3):387\u2013400","journal-title":"Cancer Cell"},{"issue":"8","key":"2280_CR70","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","volume":"79","author":"T Liu","year":"2019","unstructured":"Liu T, Jiang L, Tavana O, Gu W (2019) The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11. Cancer Res 79(8):1913\u20131924","journal-title":"Cancer Res"},{"issue":"11","key":"2280_CR71","doi-asserted-by":"publisher","first-page":"11756","DOI":"10.18632\/oncotarget.7598","volume":"7","author":"M Hasegawa","year":"2016","unstructured":"Hasegawa M, Takahashi H, Rajabi H, Alam M, Suzuki Y, Yin L, Tagde A, Maeda T, Hiraki M, Sukhatme VP et al (2016) Functional interactions of the cystine\/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget 7(11):11756\u201311769","journal-title":"Oncotarget"},{"issue":"7","key":"2280_CR72","doi-asserted-by":"publisher","first-page":"114477","DOI":"10.1016\/j.celrep.2024.114477","volume":"43","author":"YY Feng","year":"2024","unstructured":"Feng YY, Li YC, Liu HM, Xu R, Liu YT, Zhang W, Yang HY, Chen G (2024) Synthetic lethal CRISPR screen identifies a cancer cell-intrinsic role of PD-L1 in regulation of vulnerability to ferroptosis. Cell Rep 43(7):114477","journal-title":"Cell Rep"},{"issue":"9","key":"2280_CR73","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.immuni.2024.08.003","volume":"57","author":"Y Ping","year":"2024","unstructured":"Ping Y, Shan J, Qin H, Li F, Qu J, Guo R, Han D, Jing W, Liu Y, Liu J et al (2024) PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8(+) T cell ferroptosis. Immunity 57(9):2122\u20132139e2129","journal-title":"Immunity"},{"issue":"10","key":"2280_CR74","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","volume":"12","author":"S M\u00fcller","year":"2020","unstructured":"M\u00fcller S, Sindikubwabo F, Ca\u00f1eque T, Lafon A, Versini A, Lombard B, Loew D, Wu TD, Ginestier C, Charafe-Jauffret E et al (2020) CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat Chem 12(10):929\u2013938","journal-title":"Nat Chem"},{"issue":"22","key":"2280_CR75","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1158\/1078-0432.CCR-15-3115","volume":"22","author":"S Zhao","year":"2016","unstructured":"Zhao S, Chen C, Chang K, Karnad A, Jagirdar J, Kumar AP, Freeman JW (2016) CD44 expression level and isoform contributes to pancreatic cancer cell plasticity, invasiveness, and response to therapy. Clin Cancer Res 22(22):5592\u20135604","journal-title":"Clin Cancer Res"},{"issue":"44","key":"2280_CR76","doi-asserted-by":"publisher","first-page":"24153","DOI":"10.1021\/jacs.3c08032","volume":"145","author":"Q Feng","year":"2023","unstructured":"Feng Q, Fang W, Guo Y, Hu P, Shi J (2023) Nebulized therapy of early orthotopic lung cancer by iron-based nanoparticles: macrophage-regulated ferroptosis of cancer stem cells. J Am Chem Soc 145(44):24153\u201324165","journal-title":"J Am Chem Soc"},{"key":"2280_CR77","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.actbio.2024.07.020","volume":"186","author":"T Tsai","year":"2024","unstructured":"Tsai T, Wu S, Lai Y, Wang H, Hou P, Huang Y, Chen HH, Su W (2024) CD44-hyaluronan mediating endocytosis of iron-platinum alloy nanoparticles induces ferroptotic cell death in mesenchymal-state lung cancer cells with tyrosine kinase inhibitor resistance. Acta Biomater 186:396\u2013410","journal-title":"Acta Biomater"},{"issue":"7755","key":"2280_CR78","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A et al (2019) CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569(7755):270\u2013274","journal-title":"Nature"},{"issue":"2","key":"2280_CR79","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1021\/jacs.1c09753","volume":"144","author":"L Xie","year":"2022","unstructured":"Xie L, Li J, Wang G, Sang W, Xu M, Li W, Yan J, Li B, Zhang Z, Zhao Q et al (2022) Phototheranostic metal-phenolic networks with antiexosomal PD-L1 enhanced ferroptosis for synergistic immunotherapy. J Am Chem Soc 144(2):787\u2013797","journal-title":"J Am Chem Soc"},{"key":"2280_CR80","doi-asserted-by":"publisher","first-page":"212761","DOI":"10.1016\/j.bioadv.2022.212761","volume":"136","author":"Z Li","year":"2022","unstructured":"Li Z, Bu J, Zhu X, Zhou H, Ren K, Chu PK, Li L, Hu X, Ding X (2022) Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of Sorafenib and delivering modified GO-based PD-L1 SiRNAs. Biomater Adv 136:212761","journal-title":"Biomater Adv"},{"issue":"1","key":"2280_CR81","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/cancers16010155","volume":"16","author":"C Desterke","year":"2023","unstructured":"Desterke C, Xiang Y, Elhage R, Duruel C, Chang Y, Hama\u00ef A (2023) Ferroptosis inducers upregulate PD-L1 in recurrent triple-negative breast cancer. Cancers (Basel) 16(1):155","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2280_CR82","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/oncolo\/oyae006","volume":"29","author":"J Vallejo","year":"2024","unstructured":"Vallejo J, Singh H, Larkins E, Drezner N, Ricciuti B, Mishra-Kalyani P, Tang S, Beaver JA, Awad MM (2024) Impact of increasing PD-L1 levels on outcomes to PD-1\/PD-L1 Inhibition in patients with NSCLC: a pooled analysis of 11 prospective clinical trials. Oncologist 29(5):422\u2013430","journal-title":"Oncologist"},{"issue":"1","key":"2280_CR83","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, Xiao Y, Ding JH, Jin X, Ma D, Li DQ, Shi JX, Huang W, Wang YP, Jiang YZ et al (2023) Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab 35(1):84\u2013100e108","journal-title":"Cell Metab"},{"issue":"3","key":"2280_CR84","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/jitc-2023-008554","volume":"12","author":"Q Tao","year":"2024","unstructured":"Tao Q, Liu N, Wu J, Chen J, Chen X, Peng C (2024) Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-\u03b3-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors. J Immunother Cancer 12(3):692","journal-title":"J Immunother Cancer"},{"issue":"6520","key":"2280_CR85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/374327a0","volume":"374","author":"L Shapiro","year":"1995","unstructured":"Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Gr\u00fcbel G, Legrand JF, Als-Nielsen J, Colman DR, Hendrickson WA (1995) Structural basis of cell-cell adhesion by cadherins. Nature 374(6520):327\u2013337","journal-title":"Nature"},{"issue":"27","key":"2280_CR86","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1038\/s41388-022-02370-2","volume":"41","author":"Y Liu","year":"2022","unstructured":"Liu Y, Ouyang L, Mao C, Chen Y, Li T, Liu N, Wang Z, Lai W, Zhou Y, Cao Y et al (2022) PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma. Oncogene 41(27):3570\u20133583","journal-title":"Oncogene"},{"issue":"6","key":"2280_CR87","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1139\/bcb-2021-0513","volume":"100","author":"Z Liu","year":"2022","unstructured":"Liu Z, Xu Y, Liu X, Wang B (2022) PCDH7 knockdown potentiates colon cancer cells to chemotherapy via inducing ferroptosis and changes in autophagy through restraining MEK1\/2\/ERK\/c-Fos axis. Biochem Cell Biol 100(6):445\u2013457","journal-title":"Biochem Cell Biol"},{"issue":"1","key":"2280_CR88","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12903-023-03046-3","volume":"23","author":"J Xie","year":"2023","unstructured":"Xie J, Lan T, Zheng DL, Ding LC, Lu YG (2023) CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells. BMC Oral Health 23(1):329","journal-title":"BMC Oral Health"},{"key":"2280_CR89","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2024.04.226","volume":"220","author":"B Li","year":"2024","unstructured":"Li B, Wei Z, Wang Z, Xu F, Yang J, Lin B, Chen Y, Wenren H, Wu L, Guo X et al (2024) Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin\/\u03b2-catenin\/GPX4 axis in colorectal cancer. Free Radic Biol Med 220:125\u2013138","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"2280_CR90","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/neuonc\/noab114","volume":"23","author":"Z Bao","year":"2021","unstructured":"Bao Z, Hua L, Ye Y, Wang D, Li C, Xie Q, Wakimoto H, Gong Y, Ji J (2021) MEF2C Silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma. Neuro Oncol 23(12):2014\u20132027","journal-title":"Neuro Oncol"},{"issue":"11","key":"2280_CR91","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41388-023-02599-5","volume":"42","author":"AM Minikes","year":"2023","unstructured":"Minikes AM, Song Y, Feng Y, Yoon C, Yoon SS, Jiang X (2023) E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer. Oncogene 42(11):848\u2013857","journal-title":"Oncogene"},{"issue":"1","key":"2280_CR92","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/15548627.2022.2059170","volume":"19","author":"X Chen","year":"2023","unstructured":"Chen X, Song X, Li J, Zhang R, Yu C, Zhou Z, Liu J, Liao S, Klionsky DJ, Kroemer G et al (2023) Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis. Autophagy 19(1):54\u201374","journal-title":"Autophagy"},{"issue":"9","key":"2280_CR93","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrd1174","volume":"2","author":"M Shimaoka","year":"2003","unstructured":"Shimaoka M, Springer TA (2003) Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov 2(9):703\u2013716","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2280_CR94","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.semcdb.2012.04.007","volume":"23","author":"CL Buchheit","year":"2012","unstructured":"Buchheit CL, Rayavarapu RR, Schafer ZT (2012) The regulation of cancer cell death and metabolism by extracellular matrix attachment. Semin Cell Dev Biol 23(4):402\u2013411","journal-title":"Semin Cell Dev Biol"},{"issue":"5","key":"2280_CR95","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/cancers11050692","volume":"11","author":"E Cruz da Silva","year":"2019","unstructured":"Cruz da Silva E, Dontenwill M, Choulier L, Lehmann M (2019) Role of integrins in resistance to therapies targeting growth factor receptors in cancer. Cancers (Basel) 11(5):692","journal-title":"Cancers (Basel)"},{"issue":"33","key":"2280_CR96","doi-asserted-by":"publisher","first-page":"12741","DOI":"10.1074\/jbc.RA118.003017","volume":"293","author":"CW Brown","year":"2018","unstructured":"Brown CW, Amante JJ, Mercurio AM (2018) Cell clustering mediated by the adhesion protein PVRL4 is necessary for \u03b16\u03b24 integrin-promoted ferroptosis resistance in matrix-detached cells. J Biol Chem 293(33):12741\u201312748","journal-title":"J Biol Chem"},{"issue":"15","key":"2280_CR97","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.7150\/ijbs.76162","volume":"18","author":"F Li","year":"2022","unstructured":"Li F, Xu T, Chen P, Sun R, Li C, Zhao X, Ou J, Li J, Liu T, Zeng M et al (2022) Platelet-derived extracellular vesicles inhibit ferroptosis and promote distant metastasis of nasopharyngeal carcinoma by upregulating ITGB3. Int J Biol Sci 18(15):5858\u20135872","journal-title":"Int J Biol Sci"},{"issue":"11","key":"2280_CR98","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.3390\/curroncol31110545","volume":"31","author":"C Gotorbe","year":"2024","unstructured":"Gotorbe C, Segui F, Echavidre W, Durivault J, Blanchard T, Vial V, Pagnuzzi-Boncompagni M, Villeneuve R, Amblard R, Garnier N et al (2024) Exploiting integrin-\u03b1V\u03b23 to enhance radiotherapy efficacy in Medulloblastoma via ferroptosis. Curr Oncol 31(11):7390\u20137402","journal-title":"Curr Oncol"},{"issue":"4","key":"2280_CR99","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/cancers15041216","volume":"15","author":"A Nagpal","year":"2023","unstructured":"Nagpal A, Needham K, Lane DJR, Ayton S, Redvers RP, John M, Selistre-de-Araujo HS, Denoyer D, Pouliot N (2023) Integrin \u03b1v\u03b23 is a master regulator of resistance to TKI-induced ferroptosis in HER2-positive breast cancer. Cancers (Basel) 15(4):1216","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2280_CR100","doi-asserted-by":"publisher","first-page":"107202","DOI":"10.1016\/j.jbc.2024.107202","volume":"300","author":"HL Goel","year":"2024","unstructured":"Goel HL, Karner ER, Kumar A, Mukhopadhyay D, Goel S, Mercurio AM (2024) YAP\/TAZ-mediated regulation of laminin 332 is enabled by \u03b24 integrin repression of ZEB1 to promote ferroptosis resistance. J Biol Chem 300(4):107202","journal-title":"J Biol Chem"},{"issue":"10","key":"2280_CR101","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1470-2045(14)70403-6","volume":"15","author":"OL Chinot","year":"2014","unstructured":"Chinot OL (2014) Cilengitide in glioblastoma: When did it fail? Lancet Oncol 15(10):1044\u20131045","journal-title":"Lancet Oncol"},{"issue":"7","key":"2280_CR102","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/cancers11070978","volume":"11","author":"B Alday-Parejo","year":"2019","unstructured":"Alday-Parejo B, Stupp R, R\u00fcegg C (2019) Are integrins still practicable targets for anti-cancer therapy? Cancers (Basel) 11(7):978","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2280_CR103","doi-asserted-by":"publisher","first-page":"2575849","DOI":"10.1080\/19420862.2025.2575849","volume":"17","author":"MF Monroy","year":"2025","unstructured":"Monroy MF, Krumpoch M, McTeague TA, Fee A, Lee D, Zhou ZS, Lin FY (2025) Bi-functional integrin degraders cause stronger anti-proliferative effects than a blocking antibody by modulating distinct downstream signaling. MAbs 17(1):2575849","journal-title":"MAbs"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02280-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02280-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02280-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:02:01Z","timestamp":1774080121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02280-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2280"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02280-8","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"69"}}